_1137.png)
Breaking News
Wade Wilson
Jul 23 2026
1The contentious debate around semaglutide in South African healthcare extends beyond its use for obesity and type 2 diabetes, exposing deep-seated issues of access, affordability, regulation, and the pharmaceutical industry's role. At its core, the discussion highlights a significant deficit in public trust in the institutions responsible for health.
This summary is based on reporting by Mail and Guardian.
Leave a Reply
Cancel ReplyRelated News
Popular News
VOTE FOR CHAMPION
Who is the world cup winner of 2023
35%
11%
31%
17%
2%
4%
0%
Recent News
Gallery
Recent Comment
-
Thank You
-
Nice Article Brother
-
Nice blog